Wie gefährlich ist die Splenektomie bei Morbus Hodgkin?

Autor:	K. Sertl, E. Neumann, L. Howanietz
Rok vydání:	2008
Předmět:	medicine.medical_specialty business.industry medicine.medical_treatment Immunology Oophoropexy Splenectomy Medicine General Medicine business Beneficial effects Surgery
Zdroj:	DMW - Deutsche Medizinische Wochenschrift. 105:691-694
ISSN:	1439-4413 0012-0472
DOI:	10.1055/s-2008-1070731
Popis:	Serious complications aetiologically connected with the operation were found in 8 out of 51 patients (19 females, 32 males) who had undergone splenectomy for Hodgkin's disease. Weighing potential complications against the expected beneficial effects, clear indications for splenectomy are only found in stages I and IIa. In all more progressed clinical stages splenectomy should only be performed when 1) platelet deficiency existed prior to treatment, 2) additional irradiation of the splenic area is to be avoided, 3) oophoropexy is to be performed at the same time. When discussing the indication for splenectomy one should remember that a delay of treatment by approximately three weeks will result.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2806526879a71c6e0b8f7d9d437b6521 https://doi.org/10.1055/s-2008-1070731 Zobrazit plný text záznamu